Talzenna (talazoparib) is used to treat specific types of breast cancer.
Talzenna is also used in combination with enzalutamide to treat adults with prostate cancer that is HRR gene-mutated metastatic castration-resistant.
Talzenna works by stopping or slowing the growth of cancer cells. Talazoparib belongs to a class of medications , which is the commonly used name for poly (ADP-ribose) polymerase (PARP) inhibitors.
Talzenna is used to treat breast cancer in adults who have deleterious germline BRCA-mutated (gBRCAm) HER2-negative, and it is locally advanced or has spread to other parts of the body.
For more information email sales@lexionpharm.com
